Plasmafit® Revision Structan® Hip Endoprosthesis Cup

ACTIVE NOT RECRUITING

NCT04255966

Sponsor: Aesculap AG

Summary

The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.

Official title: Prospective, Multi-centric, Comparative, Long-term Clinical Follow-Up Study for the Evidence of Safety and Performance Indicators of the Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

60

Start Date

2021-04-12

Completion Date

2027-06

Last Updated

2025-04-29

Healthy Volunteers

No

Conditions

Osteolysis Arthroplasty Complications Instability of Prosthetic Joint Degenerative Osteoarthritis Rheumatic Arthritis Fractures, Hip Femoral Head Avascular Necrosis Prosthesis Failure

Interventions

DEVICE

Plasmafit® Revision Structan®

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Locations (4)

Orthopädische Klinik König-Ludwig-Haus

Würzburg, Bavaria, Germany

Herzogin Elisabeth Hospital

Braunschweig, Niedersachse, Germany

Gemeinschaftskrankenhaus Bonn

Bonn, North Rhine-Westphalia, Germany

Universitätsklinikum des Saarlandes

Homburg, Saarland, Germany

Clinical Research Directory